Successful treatment of idiopathic orbital inflammation with infliximab: An alternative to conventional steroid-sparing agents

Ophthalmic Plastic and Reconstructive Surgery

Volumn 24, Issue 5, 2008, Pages 415-417

  Miquel, Tiphaine ^a   Abad, Sébastien ^a,b   Badelon, Isabelle ^a,c   Vignal, Catherine ^c   Warzocha, Ursula ^a   Larroche, Claire ^a   Morax, Serge ^c   Dhote, Robin ^a,b  

^a AVICENNE HOSPITAL   (France)

^b Paris XIII   (France)

^c Service de chirurgie oculoplastique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; GADOLINIUM; INFLIXIMAB; METHOTREXATE; ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; ADULT; ALOPECIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DACRYOADENITIS; DEMYELINATING DISEASE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EYE PAIN; FEMALE; HISTOLOGY; HUMAN; IDIOPATHIC DISEASE; INFLAMMATION; LOW DRUG DOSE; LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; MYOSITIS; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT DISEASE; PANCYTOPENIA; PRIORITY JOURNAL; PTOSIS; VOMITING; DACRYOCYSTITIS; IMMUNOLOGY; MIDDLE AGED; ORBIT GRANULOMA;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; DACRYOCYSTITIS; FEMALE; GLUCOCORTICOIDS; GRANULOMA, PLASMA CELL, ORBITAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52649123819     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e318182a522     Document Type: Article

References (6)

1. Weber AL, Jakobiec FA, Sabates NR. Pseudotumor of the orbit. Neuroimaging Clin North Am 1996;6:93-111.
2. Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 2003;121:491-9.
3. Mombaerts I, Schlingemann RO, Goldschmeding R, et al. The surgical management of lacrimal gland pseudotumors. Ophthalmology 1996;103:1619-27.
4. Garrity JA, Coleman AW, Matteson EL, et al. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol 2004;138:925-30.
5. Wilson MW, Shergy WJ, Haik BG. Infliximab in the treatment of recalcitrant idiopathic orbital inflammation. Ophthal Plast Reconstr Surg 2004;20:381-3.
6. Adams AB, Kazim I, Lehman TJA. Treatment of orbital myositis with adalimumab (Humira). J Rheumatol 2005;32:1374-5.